西山 博之(ニシヤマ ヒロユキ)

研究者情報全体を表示

論文

• Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancer
  Shiota Masaki; Terada Naoki; Kitamura Hiroshi; Kojima Ta...
  CANCER SCIENCE/112(9)/pp.3616-3626, 2021-09
• Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis
  Kobayashi Mizuki; Narita Shintaro; Matsui Yoshiyuki; K...
  BJU INTERNATIONAL/Epub, 2021-06
  
  PubMed
• Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
  Balar Arjun V; Kamat Ashish M.; Kulkarni Girish S.; Uc...
  LANCET ONCOLOGY/22(7)/pp.919-930, 2021-07
• Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR
  Kobayashi Takashi; Ito Katsuhiro; Kojima Takahiro; Mar...
  CANCER IMMUNOLOGY IMMUNOTHERAPY/Epub, 2021-07
  
  PubMed
• Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era
  Naito Sei; Kato Tomoyuki; Numakura Kazuyuki; Hatakeyam...
  INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/26(10)/pp.1947-1954, 2021-10
• Intravesical Bacillus Calmette-Guerin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies
  Miyake Makito; Nishimura Nobutaka; Iida Kota; Fujii T...
  CANCERS/13(11), 2021-06
• Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis
  Nitta Satoshi; Kawai Koji; Kimura Tomokazu; Kandori S...
  INTERNATIONAL JOURNAL OF UROLOGY/28(8)/pp.840-847, 2021-08
• ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
  Powles Thomas; Assaf Zoe June; Davarpanah Nicole; Banc...
  NATURE/595/pp.432-437, 2021-06
• Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort
  Ito Katsuhiro; Kobayashi Takashi; Kojima Takahiro; Hik...
  CANCER MEDICINE/10(10)/pp.3188-3196, 2021-05
• Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan
  Shiga Masanobu; Nagumo Yoshiyuki; Chihara Ichiro; Nitt...
  INTERNATIONAL JOURNAL OF UROLOGY/28(8)/pp.814-819, 2021-08
• Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303
  Galsky Matthew D.; Hoimes Christopher J.; Necchi Andre...
  FUTURE ONCOLOGY/17(24)/pp.3137-3150, 2021-05
• A phase III, randomized, open-label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine plus cisplatin for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (NIAGARA).
  Powles Thomas; Meeks Joshua J.; Galsky Matt D.; Van de...
  JOURNAL OF CLINICAL ONCOLOGY/39(6::S), 2021-02
• The comparison of cytoreductive nephrectomy (CN) with tyrosine kinase inhibitor therapy alone in patients with primary metastatic renal cell carcinoma (mRCC).
  Hatakeyama Shingo; Naito Sei; Numakura Kazuyuki; Kato Re...
  JOURNAL OF CLINICAL ONCOLOGY/39(6::S), 2021-02
• Pembrolizumab for the treatment of patients with high-risk (HR) non-muscle-invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin: Extended follow-up of KEYNOTE-057 cohort A.
  Balar Arjun Vasant; Kamat Ashish M.; Kulkarni Girish S...
  JOURNAL OF CLINICAL ONCOLOGY/39(6::S), 2021-02
• Cystoscopic Imaging for Bladder Cancer Detection Based on Stepwise Organic Transfer Learning with a Pretrained Convolutional Neural Network.
  Ikeda A; Nosato H; Kochi Y; Negoro H; Kojima T; Sakanashi...
  J Endourol., 2021-03
• 後腹膜鏡下手術にて摘除した横隔膜原発気管支原生嚢胞の1例
  田中 隆造; 星 昭夫; 山口 茜; 野中 遥奈; 新田 聡; 古城 公佑; 南雲 義之; 池田 篤史; 松岡 ...
  泌尿紀要, 2020-09
• Retroperitoneal lymph node dissection for testicular cancer in a patient with a double inferior vena cava.
  Yamaguchi A; Negoro H; Kojo K; Ikeda A; Kimura T; Kandori...
  IJU Case Rep., 2021-01
• Impact of centralization in primary retroperitoneal sarcoma treatment: analysis using hospital-based cancer registry data in Japan.
  Kimura T; Kawai K; Kandori S; Nitta S; Kojo K; Nagumo Y; ...
  International Journal of clinical oncology/25(9)/p.1684, 2020-09
  
  PubMed
• Chronoradiation Therapy for Prostate Cancer: Morning Proton Beam Therapy Ameliorates Worsening Lower Urinary Tract Symptoms
  Hiromitsu Negoro; Ichiro Chihara; Akio Hoshi; Hiroyuki N...
  Journal of clinical medicine, 2020-07
  
  PubMed
• Determination of Circulating tumor DNA alterations in advanced urothelial carcinoma patients treated with pembrolizumab
  Tanuma Kozaburo; Kojima Takahiro; Shiga Masanobu; Kand...
  CANCER SCIENCE/112(1:SI)/pp.872-872, 2021-02
• The role of phospholipase D1 in carcinogenesis of bladder cancer
  Nagumo Yoshiyuki; Kandori Shuya; Tanaka Ken; Kawahara ...
  CANCER SCIENCE/112(1:SI)/pp.841-841, 2021-02
• The liposome of trehalose dimycolate from M. bovis BCG induce antitumor immunity via dendritic cells and CD8+T cells
  Shiga Masanobu; Miyazaki Jun; Nishiyama Hiroyuki; Yano...
  CANCER SCIENCE/112(1:SI)/pp.401-401, 2021-02
• Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
  Bellmunt Joaquim; Hussain Maha; Gschwend Jürgen E; Albers...
  The Lancet. Oncology/22(4)/pp.525-537, 2021-04
  
  PubMed
• Health-Related Quality of Life in Testicular Cancer Survivors in Japan: A Multi-Institutional, Cross-Sectional Study Using the EORTC QLQ-TC26
  Yamashita Shinichi; Kakimoto Kenichi; Uemura Motohide; ...
  Urology, 2021-03-27
  
  PubMed
• 生体腎移植術後早期腎機能に対するcortex recipient weight ratioの有用性についての検討
  高橋 一広; 金子 修三; 臼井 丈一; 木村 友和; 福田 将一; 星 昭夫; 西山 博之; 小田 竜也; 山縣...
  日本臨床腎移植学会雑誌 = Journal of Japanese Society for Clinical Renal Transplantation/8(2)/pp.217-224, 2020-12
  
  CiNii
• さらに表示...